These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7485095)

  • 21. Blastoid lymphocyte transformation assay in malignant tumours of lymphopoietic tissue: in Hodgkin's disease, reticulosarcoma, lymphosarcoma and chronic lymphatic leukaemia. Relationship to the clinical status and to the delayed type of hypersensitivity.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):51-6. PubMed ID: 4128515
    [No Abstract]   [Full Text] [Related]  

  • 22. A study of antibody formation in patients with malignant lymphomas.
    GELLER W
    J Lab Clin Med; 1953 Aug; 42(2):232-7. PubMed ID: 13069869
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ga-67 scintigraphy for the localization and staging of malignant lymphoma].
    Monzawa S; Karikomi M; Uno K; Itami J; Arimizu N
    Gan No Rinsho; 1988 Aug; 34(9):1059-64. PubMed ID: 3172511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CA 125 elevations in patients with malignant lymphomas.
    Fehm T; Beck E; Valerius T; Gramatzki M; Jäger W
    Tumour Biol; 1998; 19(4):283-9. PubMed ID: 9679739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mediastinal Hodgkin's disease and non-Hodgkin lymphoma in childhood].
    Kuleva SA
    Vopr Onkol; 2002; 48(6):735-7. PubMed ID: 12530278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.
    Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A;
    Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
    Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
    Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
    Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
    Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of HER-2/neu overexpression in non-Hodgkin's lymphoma.
    Lüftner D; Genvresse I; Geppert R; Kaufmann O; Dietel M; Possinger K
    Anticancer Res; 2004; 24(5B):3233-7. PubMed ID: 15510616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
    Kim H; Nathwani BN; Rappaport H
    Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Behavior of the leukocyte sedimentation rate in malignant neoplasms, Hodgkin's disease and lympho-reticulosarcoma].
    Colantuono A; Maccauro L
    Rass Int Clin Ter; 1967 May; 47(9):491-504. PubMed ID: 4887990
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
    Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
    J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated hyaluronan blood concentrations in severely burned patients.
    Onarheim H; Reed RK; Laurent TC
    Scand J Clin Lab Invest; 1991 Dec; 51(8):693-7. PubMed ID: 1806984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound examination of pathological cervical lymph nodes in patients with non-Hodgkin's lymphoma and Hodgkin's disease.
    Gerrits CJ; van Overhagen H; van Lom K; Adriaansen HJ; Löwenberg B
    Br J Haematol; 1994 Nov; 88(3):626-8. PubMed ID: 7819079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of plasma levels in malignant lymphoma.
    Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
    Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk-adjusted prognostic models for Hodgkin's disease (HD) and grade II non-Hodgkin's lymphoma (NHL II): validation on 6728 British National Lymphoma Investigation patients.
    Low SE; Horsman JM; Walters SJ; Hancock H; Smith P; Linch D; Hancock BW
    Br J Haematol; 2003 Jan; 120(2):277-80. PubMed ID: 12542487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of bone marrow findings to serum protein changes in lymphosarcoma, chronic lymphocytic leukemia and Hodgkin's disease.
    ONAT A; COOPER T
    Blood; 1960 Jan; 15():114-29. PubMed ID: 14428869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.